The Clinical Impact of Time-restricted Eating on Cancer: A Systematic Review
Nutrition Reviews · 01.07.2025 · 83 (7) · e1660-e1676
DOI: 10.1093/nutrit/nuae105 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Nutrition Reviews, online erschienen am 30.08.2024. Verfasst von Eleah J Stringer und 5 weiteren Autor:innen. Beteiligte Einrichtung: Nursing and Allied Health Research and KT Department, BC Cancer, Vancouver, BC V5Z 1G1, Canada. Hauptthemen laut MEDLINE: Neoplasms, Fasting. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Michael Smith Health Research, BC Cancer Foundation, CIHR.
Abstract (Originalsprache)
Context
In the face of the growing global burden of cancer, there is increasing interest in dietary interventions to mitigate its impacts. Pre-clinical evidence suggests that time-restricted eating (TRE), a type of intermittent fasting, induces metabolic effects and alterations in the gut microbiome that may impede carcinogenesis. Research on TRE in cancer has progressed to human studies, but the evidence has yet to be synthesized.
Objective
The objective of this study was to systematically evaluate the clinical and/or metabolomic effects of TRE compared with ad libitum eating or alternative diets in people with cancer. Data Sources Ovid MEDLINE, Ovid Embase, CINAHL, Ovid Cochrane Central Register of Control Trials (CENTRAL), Web of Science Core Collection (ESCI, CPCI-SSH, CPCI-S), and SCOPUS were searched up to January 4, 2023, using the core concepts of “intermittent fasting” and “cancer.” Original study designs, protocols, and clinical trial registries were included. Data Extraction After evaluating 13 900 results, 24 entries were included, consisting of 8 full articles, 2 abstracts, 1 published protocol and 13 trial registries. All data were extracted, compared, and critically analyzed. Data Analysis There was heterogeneity in the patient population (eg, in tumor sites), TRE regimens (eg, degree of restriction, duration), and clinical end points. A high rate (67–98%) of TRE adherence was observed, alongside improvements in quality of life. Four articles assessed cancer markers and found a reduction in tumor marker carcinoembryonic antigen, reduced rates of recurrence, and a sustained major molecular response, following TRE. Five articles demonstrated modified cancer risk factors, including beneficial effects on body mass index, adiposity, glucoregulation, and inflammation in as short a period as 8 weeks. None of the completed studies assessed the effect of TRE on the microbiome, but analysis of the microbiome is a planned outcome in 2 clinical trials.
Conclusions
Preliminary findings suggest that TRE is feasible and acceptable by people with cancer, may have oncological benefits, and improves quality of life. Registration PROSPERO registration No. CRD42023386885.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Nursing and Allied Health Research and KT Department, BC Cancer, Vancouver, BC V5Z 1G1, Canada.
- Department of Oncology Nutrition, BC Cancer, Victoria, BC V8R 6V5, Canada.
- Food, Nutrition and Health, Faculty of Land and Food Systems, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.
- Department of Microbiology and Immunology, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.
- School of Population and Public Health, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
- Department of Cancer Control Research, BC Cancer Research Institute, Vancouver, BC V5Z 1L3, Canada.
ORCID-Profile: Eleah J Stringer
Förderung
- Michael Smith Health Research
- BC Cancer Foundation
- CIHR
- Terry Fox Research Institute
- Lotte and John Hecht Memorial Foundation
- Michael Smith Health Research BC
- Lotte & John Hecht Memorial Foundation
- Terry Fox Research Institute New Frontiers Program
Zitieren
APA
Stringer, E. J., Cloke, R. W. G., Van der Meer, L., Murphy, R. A., Macpherson, N. A., & Lum, J. J. (2025). The Clinical Impact of Time-restricted Eating on Cancer: A Systematic Review. Nutrition Reviews, 83(7), e1660-e1676. https://doi.org/10.1093/nutrit/nuae105
Vancouver
Stringer EJ, Cloke RWG, Van der Meer L, Murphy RA, Macpherson NA, Lum JJ. The Clinical Impact of Time-restricted Eating on Cancer: A Systematic Review. Nutrition Reviews. 2025;83(7):e1660-e1676. doi:10.1093/nutrit/nuae105
BibTeX
@article{Stringer2025,
author = {Stringer, Eleah J and Cloke, Rob W G and Van der Meer, Lindsay and Murphy, Rachel A and Macpherson, Nicol A and Lum, Julian J},
title = {The Clinical Impact of Time-restricted Eating on Cancer: A Systematic Review},
journal = {Nutrition Reviews},
year = {2025},
volume = {83},
number = {7},
pages = {e1660--e1676},
doi = {10.1093/nutrit/nuae105}
}
EUVIMED